International biomedical leaders in inflammasome R&D
Viva In Vitro has raised $1.4M in total funding. The most recent round was Seed. The last funding was announced in July 2024.
Viva In Vitro's investors include ENISA, Vincle Capital, Murcia Emprende, Rafael Crespo Carretero, Rocosta Capital.
Viva In Vitro is headquartered in Murcia, Spain.
International biomedical leaders in inflammasome R&D
Viva In Vitro is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Viva In Vitro — Funding & Investors." VCBacked, July 8, 2024, https://www.vcbacked.co/company/viva-in-vitro. Accessed August 14, 2026.
VCBacked. (2024). Viva In Vitro — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/viva-in-vitro
{{cite web |title=Viva In Vitro — Funding & Investors |url=https://www.vcbacked.co/company/viva-in-vitro |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated